Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMTOX-25 in Refractory/Relapsed CD25+ Adult T Cell Leukemia/Lymphoma
NCT01378871Phase 2Terminated
- Start
- Sep 2010
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Antibody-Drug Conjugates (ADCs), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of RFT5-SMPT-dgA in adult T-cell leukemia-lymphoma (ATLL). Started Sep 2010; status: terminated.
02
Drugs
RFT5-SMPT-dgA
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT01378871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378871.